Bit.bio reveals early pipeline of regenerative medicine candidates
Endpoints News - 08-Nov-2023Lead program bbHEP01 targets severe acute liver failure, with phase I trial planned for 2025
Join the club for FREE to access the whole archive and other member benefits.
Biopharma Breaking News Reporter at Endpoints News
Ayisha Sharma is currently working as biopharma breaking news reporter at Endpoints. Prior to this, she was a healthcare reporter at Citeline and Compose.ly, as well as investigative journalist at GlobalData Insights.
Ayisha holds an MA in Philosophy from University College London as well as a diploma in multimedia journalism.
Visit website: https://endpts.com/author/ayisha-sharma/
See alsoDetails last updated 09-Nov-2023
Lead program bbHEP01 targets severe acute liver failure, with phase I trial planned for 2025